AU2002254128A1 - Feline immunodeficiency virus central dna flap - Google Patents

Feline immunodeficiency virus central dna flap

Info

Publication number
AU2002254128A1
AU2002254128A1 AU2002254128A AU2002254128A AU2002254128A1 AU 2002254128 A1 AU2002254128 A1 AU 2002254128A1 AU 2002254128 A AU2002254128 A AU 2002254128A AU 2002254128 A AU2002254128 A AU 2002254128A AU 2002254128 A1 AU2002254128 A1 AU 2002254128A1
Authority
AU
Australia
Prior art keywords
immunodeficiency virus
feline immunodeficiency
dna flap
central dna
virus central
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002254128A
Other versions
AU2002254128A8 (en
Inventor
Eric M. Poeschla
Todd A. Whitwam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Original Assignee
Mayo Foundation for Medical Education and Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research filed Critical Mayo Foundation for Medical Education and Research
Publication of AU2002254128A1 publication Critical patent/AU2002254128A1/en
Publication of AU2002254128A8 publication Critical patent/AU2002254128A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
AU2002254128A 2001-03-07 2002-03-06 Feline immunodeficiency virus central dna flap Abandoned AU2002254128A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27401301P 2001-03-07 2001-03-07
US60/274,013 2001-03-07
PCT/US2002/006818 WO2002072756A2 (en) 2001-03-07 2002-03-06 Feline immunodeficiency virus central dna flap

Publications (2)

Publication Number Publication Date
AU2002254128A1 true AU2002254128A1 (en) 2002-09-24
AU2002254128A8 AU2002254128A8 (en) 2005-11-17

Family

ID=23046400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002254128A Abandoned AU2002254128A1 (en) 2001-03-07 2002-03-06 Feline immunodeficiency virus central dna flap

Country Status (2)

Country Link
AU (1) AU2002254128A1 (en)
WO (1) WO2002072756A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003301353A1 (en) * 2002-10-18 2004-05-04 Cylene Pharmaceuticals Processes for identifying quadruplex-targeted antiviral molecules

Also Published As

Publication number Publication date
AU2002254128A8 (en) 2005-11-17
WO2002072756A3 (en) 2005-07-28
WO2002072756A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
AU2002335613A1 (en) Biochips comprising nucleic acid/protein conjugates
AU2002367748A1 (en) Infectious disease microarray
AU2002336367A1 (en) Adamts13 genes and proteins and variants, and uses thereof
AU2002233543A1 (en) Novel p53-inducible protein
AU2002367108A1 (en) Dna vaccine for periodontal disease
AU2002358273A1 (en) Nucleic acid-associated proteins
AU2001233513A1 (en) Hiv-1 resistance assay
AU2002254128A1 (en) Feline immunodeficiency virus central dna flap
AU2002314356A1 (en) A protein folding reactor
AU2002359333A1 (en) Nucleic acid-associated proteins
AU2002343043A1 (en) Processing nucleic acid
AU2002314274A1 (en) Vaccination against the feline immunodeficiency virus
AU2002355292A1 (en) Nucleic acid-associated proteins
AU2002319311A1 (en) Universal stacker
AU2001297753A1 (en) Yeast genes that affect viral replication
AU2003241762A1 (en) Dna shuflling
AU2002326332A1 (en) Nucleic acid-associated proteins
AU2002364926A1 (en) Nucleic acid-associated proteins
AU2002256065A1 (en) Nucleic acid-associated proteins
AU2002256993A1 (en) Nucleic acid-associated proteins
AU2002345051A1 (en) Bace interacting proteins
AUPR282501A0 (en) Expression facilitating nucleotides
AU2002319485A1 (en) Dna vaccine
AU2001290565A1 (en) Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof
AU2002324847A1 (en) Dna binding protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase